32 Stocks Moving in Tuesday's Pre-Market Session

Loading...
Loading...

Gainers

  • CymaBay Therapeutics, Inc. CBAY shares rose 143.5% to $4.48 in pre-market trading after the company announced an independent expert panel unanimously concluded there is no evidence of liver injury in the Phase 2b NASH study of seladelpar. The panel supported re-initiating development of seladelpar. The company also reported narrower-than-expected Q1 loss. Raymond James and Evercore ISI Group upgraded CymaBay Therapeutics to Outperform.
  • Gamida Cell Ltd. GMDA rose 89.4% to $8.60 in pre-market trading after the company reported positive topline data from Phase 3 clinical study of Omidubicel in patients with high-risk hematologic malignancies.
  • American Outdoor Brands Corporation AOBC rose 45.2% to $15.11 in pre-market trading.
  • Akorn, Inc. AKRX rose 39.4% to $0.3550 in pre-market trading following Q1 results. Akorn posted Q1 earnings of $0.36 per share, versus a year-ago loss of $0.10 per share.
  • Novavax, Inc. NVAX rose 34.5% to $32.96 in pre-market trading after the company reported better-than-expected Q1 results. The company also announced it will receive up to $388 million in funding from CEPI for COVID-19 (coronavirus) vaccine development and manufacturing.
  • Fluent, Inc. FLNT rose 32.1% to $3.00 in pre-market trading following better-than-expected Q1 results.
  • II-VI, Inc. IIVI rose 27% to $46.00 in pre-market trading after the company reported better-than-expected Q3 sales.
  • YRC Worldwide Inc. YRCW rose 25.7% to $1.86 in pre-market trading after the company reported better-than-expected Q1 results.
  • MicroVision, Inc. MVIS shares rose 25.2% to $1.05 in pre-market trading as traders circulate an unknown source article from Florida Independent titled 'Microsoft's Acquisition of Microvision Confirmed.'
  • NanoViricides Inc NNVC rose 19.8% to $8.52 in pre-market trading after the company developed highly effective broad-spectrum drug candidates against coronaviruses.
  • Chaparral Energy, Inc. CHAP rose 18.2% to $0.5081 in pre-market trading following Q1 results. Chaparral Energy reported Q1 EPS of $0.23.
  • MacroGenics, Inc. MGNX rose 16.2% to $30.58 in pre-market trading after surging over 29% on Monday.
  • Brighthouse Financial Inc BHF rose 14% to $32.00 in pre-market trading after the company reported better-than-expected Q1 earnings.
  • Invesco Mortgage Capital Inc. IVR rose 11.5% to $2.91 in pre-market trading after the company reported common and preferred stock dividend payment dates.
  • International Flavors & Fragrances Inc. IFF rose 8.4% to $143.70 in pre-market trading after the company reported better-than-expected Q1 results.
  • AMC Entertainment Holdings, Inc. AMC rose 7.1% to $5.70 in pre-market trading after jumping around 30% on Monday.
  • Grocery Outlet Holding Corp GO rose 5% to $38.50 in pre-market trading after the company reported better-than-expected Q1 results and comparable store sales up 17.4%.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Genfit SA GNFT fell 63.2% to $7.98 in pre-market trading after the company disclosed results from an interim study of RESOLVE-IT Phase 3 trial.
  • Rand Capital Corporation RAND shares fell 31.1% to $2.06 in pre-market trading. Rand Capital shares climbed 8% on Monday after the company reported Q1 results.
  • Advanced Emissions Solutions, Inc. ADES fell 25.2% to $5.80 in pre-market trading after reporting Q1 results. Advanced Emissions Solutions posted a Q1 loss of $0.11 per share.
  • California Resources Corporation CRC fell 23.4% to $1.86 in pre-market trading.
  • Nabriva Therapeutics plc NBRV fell 11% to $0.65 in pre-market trading after the company reported wider-than-expected Q1 loss.
  • Eventbrite Inc EB shares fell 10.7% to $9.40 in pre-market trading after the company reported worse-than-expected Q1 results.
  • Marker Therapeutics, Inc. MRKR fell 10.1% to $2.23 in pre-market trading following downbeat Q1 earnings. Piper Sandler downgraded Marker Therapeutics from Overweight to Neutral and lowered the price target from $5 to $2.5.
  • AgEagle Aerial Systems, Inc. UAVS fell 9.4% to $1.34 in pre-market trading after surging around 40% on Monday.
  • Genius Brands International, Inc. GNUS fell 9.3% to $0.73 in pre-market trading after jumping 39% on Monday.
  • DBV Technologies S.A. DBVT shares fell 8.6% to $5.63 in pre-market trading.
  • CPS Technologies Corporation CPSH fell 8.5% to $1.40 in pre-market trading after rising around 9% on Monday.
  • Halozyme Therapeutics, Inc. HALO fell 7.3% to $23.00 in pre-market trading after the company reported worse-than-expected Q1 results.
  • Akebia Therapeutics, Inc. AKBA fell 6.6% to $12.00 in pre-market trading after the company announced a proposed $100 million public offering of common stock.
  • The Chefs' Warehouse, Inc. CHEF fell 6% to $13.75 in pre-market trading after the company reported a proposed public offering of common stock.
  • Tencent Music Entertainment Group - ADR TME fell 4.3% to $10.92 in pre-market trading after the company reported worse-than-expected Q1 results.
Loading...
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...